ClassID:

110830

C12N2760/16221 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus B, i.e. influenza B virus Viruses as such, e.g. new isolates, mutants or their genomic sequences

Recent Application in this class:
#1
20260041756
2026-02-12

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

#2
20240150409
2024-05-09

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

#3
20240091337
2024-03-21

INFLUENZA B VIRUS MUTANTS AND USES THEREFOR

#4
20220202926
2022-06-30

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

#5
20220160863
2022-05-26

HIGH GROWTH INFLUENZA VIRUS

#6
20220003767
2022-01-06

METHOD

#7
20210206812
2021-07-08

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

#8
20210101458
2021-04-08

Fabric top for a convertible vehicle and convertible vehicle

#9
20200360508
2020-11-19

H7 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application

#10
20200318078
2020-10-08

H9 avian influenza vaccine strain which differentiates infected from vaccinated animals, and preparation method therefor

#11
20200282045
2020-09-10

Influenza B virus mutants and uses therefor

#12
20200282044
2020-09-10

H5 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application

#13
20200172877
2020-06-04

INFLUENZA VIRUS REASSORTMENT

#14
20170258888
2017-09-14

Influenza B virus replication for vaccine development

#15
20160362454
2016-12-15

Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses

#16
20160279227
2016-09-29

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

#17
20150353900
2015-12-10

Influenza virus reassortment

#18
20140341948
2014-11-20

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

#19
20140335117
2014-11-13

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

#20
20120258134
2012-10-11

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

#21
20110212117
2011-09-01

Influenza hemagglutinin and neuraminidase variants

#22
20100233785
2010-09-16

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

#23
20100158942
2010-06-24

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

#24
20090203114
2009-08-13

Methods for the propagation of modified influenza viruses in embryonated eggs

#25
20090053264
2009-02-26

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

#26
20080293040
2008-11-27

Influenza B viruses with reduced sensitivity to neuraminidase inhibitors

#27
20080050403
2008-02-28

Production of viruses, viral isolates and vaccines

#28
20050123564
2005-06-09

Production of viruses viral isolates and vaccines

#29
20050054074
2005-03-10

Methods and interferon deficient substrates for the propagation of viruses